• 1
    Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984; 29: 913920.
  • 2
    Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992; 102: 19401948.
  • 3
    Torres EA, De JR, Perez CM, et al. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P R Health Sci J. 2003; 22: 253258.
  • 4
    Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000; 231: 3845.
  • 5
    Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort. Am J Gastroenterol. 2006; 101: 10121023.
    Direct Link:
  • 6
    Cross RK, Jung C, Wasan S, et al. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006; 12: 192198.
  • 7
    SmedleyBD, StithAY, NelsonAR, et al, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2005: 179.
  • 8
    Jha AK, Fisher ES, Li Z, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005; 353: 683691.
  • 9
    Nguyen GC, LaVeist TA, Gearhart SL, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol. 2006; 4: 15071513.
  • 10
    Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev. 2000; 22: 187202.
  • 11
    Lillie-Blanton M, Laveist T. Race/ethnicity, the social environment, and health. Soc Sci Med. 1996; 43: 8391.
  • 12
    Straus WL, Eisen GM, Sandler RS, et al. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol. 2000; 95: 479483.
    Direct Link:
  • 13
    Whalen D, Houchens R, Elixhauser A. 2002 HCUP Nationwide Inpatient Sample (NIS) Comparison Report. U.S. Agency for Healthcare Research and Quality; 2005; 189
  • 14
    Farrokhyar F, McHugh K, Irvine EJ. Self-reported awareness and use of the International Classification of Diseases coding of inflammatory bowel disease services by Ontario physicians. Can J Gastroenterol. 2002; 16: 519526.
  • 15
    Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 11301139.
  • 16
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613619.
  • 17
    Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care. 2002; 40: 675685.
  • 18
    Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care. 2004; 42: 801809.
  • 19
    Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749753.
  • 20
    Ayanian JZ, Cleary PD, Weissman JS, et al. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999; 341: 16611669.
  • 21
    Kressin NR, Chang BH, Whittle J, et al. Racial differences in cardiac catheterization as a function of patients' beliefs. Am J Public Health. 2004; 94: 20912097.
  • 22
    Rosenberg M, Cohen F. Medicaid and physician reimbursement. Pediatrics. 2006; 118: 808809.
  • 23
    Wang EC, Choe MC, Meara JG, et al. Inequality of access to surgical specialty health care: why children with government-funded insurance have less access than those with private insurance in Southern California. Pediatrics. 2004; 114: e584e590.
  • 24
    Access of Medicaid recipients to outpatient care. N Engl J Med. 1994; 330: 14261430.
  • 25
    Asplin BR, Rhodes KV, Levy H, et al. Insurance status and access to urgent ambulatory care follow-up appointments. JAMA. 2005; 294: 12481254.
  • 26
    Rubenstein JH, Chong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol. 2002; 35: 151156.
  • 27
    Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005; 128: 862869.
  • 28
    Kressin NR, Chang BH, Hendricks A, et al. Agreement between administrative data and patients' self-reports of race/ethnicity. Am J Public Health. 2003; 93: 17341739.
  • 29
    Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002; 359: 248252.